Back to search

Article

The Allocation of US$ 105 Billion in Global Funding for Infectious Disease Research between 2000 and 2017: An Analysis of Investments from Funders in the G20 Countries

2020-04-01

Abstract excerpt

Background: Each year, billions of dollars are spent globally on infectious disease research and development (R&D). However, there is little systematic tracking of global R&D.<br><br>Methods: The study examined research awards made between 2000 and 2017 for infectious disease research from G20-based public and philanthropic funders. Research databases were searched using a range of keywords, and open data was extr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f80b40cc-d593-5193-adf0-5beaab5f01f1
DOI
10.2139/ssrn.3552831
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Allocation of US$ 105 Billion in Global Funding for Infectious Disease Research between 2000 and 2017: An Analysis of Investments from Funders in the G20 CountriesDOI 10.2139/ssrn.3552831
Living mapping review of global research funding for infectious diseases with a pandemic potential – Pandemic PACT Grant TrackerSemantic proximity
Living mapping review of global research funding for pandemic-prone infectious diseases– Pandemic PACT Grant TrackerSemantic proximity
The role of NIH funding in vaccine readiness; foundational research and NIH funding underlying candidate SARS-CoV-2 vaccinesSemantic proximity
Financing global health security: estimating the costs of pandemic preparedness in Global Fund eligible countriesSemantic proximity
Investing in Global Health Security: Estimating Cost Requirements for Global Capacity BuildingSemantic proximity
Training Needs for Emerging Infectious Diseases Research, Surveillance and Control in High-Risk and Resource-Constrained Settings: Findings and Recommendations for UgandaSemantic proximity
To fully tackle the gang of four, needs-driven R & D is essential. Authors' reply [6].Semantic proximity
Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statementSemantic proximity
Measuring the Impact of Global R&D Investment in Product Development Partnerships (PDPs): A Case Study on Return on Investment in Antimalarial Drug DevelopmentSemantic proximity
<strong>COVID19 PCR Testing and the Unprecedented Institutional Response in a Low-Resource Setting</strong>Semantic proximity
Developing an Aggregator Mechanism for Late-Stage Clinical Trials of Neglected Disease Product CandidatesSemantic proximity
The 10-year health impact, economic impact, and return on investment of the South African molecular diagnostics programme for HIV, Tuberculosis and SARS-CoV-2Semantic proximity
Select a neighboring publication to make it the new centre.